QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial 期刊论文 CLINICAL CANCER RESEARCH, 2021, 卷号: 27 作者:  Li, Dapeng;  Chi, Yihebali;  Chen, Xiaohong;  Ge, Minghua;  Zhang, Yuan 收藏  |  浏览/下载：35/0  |  提交时间：2021/08/31 Updated results of ALTER-C002: Anlotinib combined with CAPEOX in first-line treatment of patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Ding, Ke-Feng;  Liu, Yue;  Du, Jinlin;  Zhu, Yuping;  Liu, Zhuo 收藏  |  浏览/下载：34/0  |  提交时间：2022/01/10 A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM). 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Li, Peijing;  Chen, Yuan Yuan Yuan;  Lai, Shuzhen;  Jiang, Fagui;  Liu, Xiaohui 收藏  |  浏览/下载：19/0  |  提交时间：2022/01/10 A phase II study of anlotinib in the first-line treatment of locally advanced or metastatic soft tissue sarcoma. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Huang, Xin;  Ye, Zhaoming;  Li, Tao;  Wei, Yongzhong;  Wang, Shoufeng 收藏  |  浏览/下载：21/0  |  提交时间：2022/01/10 Combination of sintilimab, anlotinib and pegaspargase "sandwich" with radiotherapy in localized natural killer/T cell lymphoma: A multicenter, phase 2 study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Li, Zhiming;  Sun, Peng;  Wang, Yu;  Yang, Hang;  Li, Yajun 收藏  |  浏览/下载：26/0  |  提交时间：2022/01/10 Anlotinib plus docetaxel versus docetaxel as second-line treatment for advanced non-small cell lung cancer (NSCLC): Updated results from a phase I/II study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Fang, Yong;  Pan, Hongming;  Shou, Jiawei;  Hong, Wei;  Guo, Qunyi 收藏  |  浏览/下载：15/0  |  提交时间：2022/01/10 Anlotinib in radioiodine-refractory differentiated thyroid carcinoma: A subanalysis based on ALTER01032 study for patients with poor baseline characteristics. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Chi, Yihebali;  Gao, Ming;  Zhang, Yuan;  Shi, Feng;  Cheng, Ying 收藏  |  浏览/下载：20/0  |  提交时间：2022/01/10 Anlotinib plus Docetaxel versus Docetaxel as 2nd Line Treatment in Advanced Non-Small Cell Lung Cancer: A Phase I/II Study 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16 作者:  Fang, Y.;  Pan, H.;  Shou, J.;  Hong, W.;  Yang, X. 收藏  |  浏览/下载：55/0  |  提交时间：2021/05/17 Anlotinib  NSCLC  anti-angiogenesis   Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan 收藏  |  浏览/下载：30/0  |  提交时间：2021/03/15 Anlotinib  Immunotherapy  Programmed death 1 inhibitor  Lung cancer